Lam Ranked as Leading Healthcare Lawyer in North America by MergerLinks

David Lam has been recognized by MergerLinks as the second-ranked healthcare lawyer in North America for 2023.

Notably, in 2023, David led deal teams representing Pfizer in its $43 billion acquisition of Seagen and AbbVie in its $10.1 billion acquisition of ImmunoGen.

David’s practice focuses on mergers and acquisitions, securities transactions and corporate governance, serving clients in a variety of industries. He also advises numerous companies on takeover defenses, proxy contests and corporate governance matters.

Click here to read more.